Frunevetmab, a felinized anti‐nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats

Journal of Veterinary Internal Medicine

Margaret E. Gruen¹  B. Duncan X. Lascelles²  Csilla Becskei³  Jamie A. E. Myers⁴  Dawn M. Cleaver⁴  Jezaniah‐Kira S. Tena⁴ 

[1] Translational Research in Pain (TRiP) Program, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA;Behavioral Medicine, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA;Comparative Pain Research and Education Center, North Carolina State University, Raleigh, North Carolina, USA;Translational Research in Pain (TRiP) Program, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA;Comparative Pain Research and Education Center, North Carolina State University, Raleigh, North Carolina, USA;Thurston Arthritis Center, UNC School of Medicine, Chapel Hill, North Carolina, USA;Center for Translational Pain Research, Department of Anesthesiology, Duke University, Durham, North Carolina, USA;Veterinary Medicine Research and Development, Zoetis Belgium SA, Zaventem, Belgium;Veterinary Medicine Research and Development, Zoetis Inc, Kalamazoo, Michigan, USA;

关键词: arthritis;    client specific outcome measures;    CSOM;    degenerative joint disease;    feline;    feline musculoskeletal pain index;    FMPI;   

DOI  :  10.1111/jvim.16291

来源: Wiley

【 授权许可】

CC BY